Literature DB >> 26685727

Evaluation of the versatile character of a nanoemulsion formulation.

E Gué1, M Since1, S Ropars1, R Herbinet2, L Le Pluart2, A Malzert-Fréon3.   

Abstract

The formulate-ability of six model active pharmaceutical ingredients (API), with different physico-chemical profiles, in a nanoemulsion designed to be intraveinously administrable was explored. Nanoemulsions were spontaneously generated at room temperature by pouring a phosphate buffer in an anhydrous mixture containing pharmaceutically acceptable triglycerides and non-ionic surfactants. After determination of the apparent solubility of each API in excipients and characterization of mixtures by DSC, API-loaded nanoemulsions were formulated and characterized in terms of granulometric properties, surface potential, drug recovery efficiency, pH, osmolarity, in vitro drug release, and stability. Except ciprofloxacin, a BCS class IV drug, all studied APIs were soluble in at least one excipient used, i.e. Labrasol. At 2 wt% API, all drug-loaded nanoemulsions present properties compatible with i.v. administration. The formulation should permit to increase apparent solubility of poorly water-soluble APIs, and also to prolong delivery of hydrophobic as well of more hydrophilic compounds. Herein, the relative affinity of the API for nanodroplets and the release medium would directly influence drug release profiles. Nanoemulsions were stable for 7 days. They could also been extemporaneously reconstituted before use. Such a versatile nanoemulsion would provide a valuable option as formulation strategy for improvement of drug properties.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apparent solubility; Labrasol(®); Nanoemulsion; Parenteral administration; Self-emulsification

Mesh:

Substances:

Year:  2015        PMID: 26685727     DOI: 10.1016/j.ijpharm.2015.12.010

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

1.  Improved Pharmacodynamic Potential of Rosuvastatin by Self-Nanoemulsifying Drug Delivery System: An in vitro and in vivo Evaluation.

Authors:  Ravinder Verma; Ajeet Kaushik; Rafa Almeer; Md Habibur Rahman; Mohamed M Abdel-Daim; Deepak Kaushik
Journal:  Int J Nanomedicine       Date:  2021-02-09

2.  Formulation Strategies to Improve Nose-to-Brain Delivery of Donepezil.

Authors:  Lupe Carolina Espinoza; Marcelle Silva-Abreu; Beatriz Clares; María José Rodríguez-Lagunas; Lyda Halbaut; María-Alexandra Cañas; Ana Cristina Calpena
Journal:  Pharmaceutics       Date:  2019-02-01       Impact factor: 6.321

3.  Impact of different emulsifiers on biocompatibility and inflammatory potential of Perfluorohexyloctane (F6H8) emulsions for new intravenous drug delivery systems.

Authors:  Charalambos Tsagogiorgas; Friedrich Anger; Grietje Beck; Annette Breedijk; Benito Yard; Simone Hoeger
Journal:  Drug Des Devel Ther       Date:  2019-06-27       Impact factor: 4.162

4.  Apremilast Microemulsion as Topical Therapy for Local Inflammation: Design, Characterization and Efficacy Evaluation.

Authors:  Paulo Sarango-Granda; Marcelle Silva-Abreu; Ana Cristina Calpena; Lyda Halbaut; María-José Fábrega; María J Rodríguez-Lagunas; Natalia Díaz-Garrido; Josefa Badia; Lupe Carolina Espinoza
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-21

5.  Design of Non-Haemolytic Nanoemulsions for Intravenous Administration of Hydrophobic APIs.

Authors:  Line Séguy; Anne-Claire Groo; Didier Goux; Didier Hennequin; Aurélie Malzert-Fréon
Journal:  Pharmaceutics       Date:  2020-11-25       Impact factor: 6.321

6.  Optimization of Surfactant- and Cosurfactant-Aided Pine Oil Nanoemulsions by Isothermal Low-Energy Methods for Anticholinesterase Activity.

Authors:  Mayank Handa; Rewati Raman Ujjwal; Nupur Vasdev; S J S Flora; Rahul Shukla
Journal:  ACS Omega       Date:  2020-12-30

7.  Design and optimization of candesartan loaded self-nanoemulsifying drug delivery system for improving its dissolution rate and pharmacodynamic potential.

Authors:  Ravinder Verma; Deepak Kaushik
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.